HomeJNY • FRA
JW (Cayman) Therapeutics Co Ltd
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 35.70M | -17.09% |
Operating expense | 126.04M | -17.35% |
Net income | -175.18M | 9.60% |
Net profit margin | -490.68 | -9.02% |
Earnings per share | — | — |
EBITDA | -89.89M | 20.26% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 757.38M | -25.12% |
Total assets | 1.68B | -21.70% |
Total liabilities | 511.20M | 10.59% |
Total equity | 1.17B | — |
Shares outstanding | 414.19M | — |
Price to book | 0.05 | — |
Return on assets | -16.25% | — |
Return on capital | -17.16% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -175.18M | 9.60% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
€0.14
Day range
€0.15 - €0.15
Year range
€0.13 - €0.29
Market cap
578.39M HKD
Avg Volume
21.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
About
CEO
Founded
2016
Website
Employees
281
